Improvement in renal function in hepatorenal syndrome with N-acetylcysteine

Lancet

Volumn 353, Issue 9149, 1999, Pages 294-295

  Holt, S ^a   Goodier, D ^a   Marley, R ^a   Patch, D ^a   Burroughs, A ^a   Fernando, B ^a   Harry, D ^a   Moore, K ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE;

ARTICLE; CLINICAL ARTICLE; HEPATORENAL SYNDROME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; PRIORITY JOURNAL;

EID: 0033060562     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)74933-3     Document Type: Article

References (5)

1. M Epstein Hepatorenal syndrome. The kidney in liver disease 1996 Hanley & Belfus Philadelphia 75 108
2. SP Wilkinson MJ Weston V Parsons R Williams Dialysis in the treatment of renal failure in patients with liver disease Clin Nephrol 8 1977 287 292
3. SG Holt R Marley B Fernando Acute cholestasis-induced renal failure: effects of anti-oxidants and ligands for the TxA2 receptor Kidney Int 55 1998 271 277
4. R Keays PM Harrison JA Wendon Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial BMJ 303 1991 1026 1029
5. V Arroyo P Gines AL Gerbes Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club Hepatology 23 1996 164 176